Meta-Analysis of Studies on the Effects of Digital Therapeutics

Author:

Seo Young-Chul1,Yong Sang Yeol1ORCID,Choi Won Woo2ORCID,Kim Sung Hoon1

Affiliation:

1. Wonju College of Medicine, Yonsei University, 20, Ilsan-ro, Wonju-si 26426, Gangwon-do, Republic of Korea

2. Department of Rehabilitation Medicine, Yonsei University, 20, Ilsan-ro, Wonju-si 26426, Kangwon-do, Republic of Korea

Abstract

Digital therapeutics (DTx), novel treatment methods that have the potential to surpass traditional approaches such as pills, have received considerable research attention. Various efforts have been made to explore effective treatment methods that actively integrate DTx. This review investigates DTx treatment outcomes comprehensively through a meta-analysis. The analysis—a manual search of studies on “digital therapeutics”—includes DTx studies from January 2017 to October 2022. Hedges’ g is used to quantify effect size for fifteen studies analyzed, encompassing eight control groups. Further, a quality assessment is performed using the Bias Risk Assessment Tool. The Hedges’ g analysis results provide weighted average effect sizes across the eight control groups, revealing a substantial value of 0.91 (95% CI: 0.62 to 1.20); this signifies a moderate to large effect size. Further refinement, which excludes one study, yields an increased weighted average effect size of 1.13 (95% CI: 0.91 to 1.36). The quality assessment results consistently indicate a low risk of bias across studies. The meta-analysis results indicate that DTx can provide significant pivotal therapeutic impacts and offer a means to personalize treatment approaches and streamline the management of patients’ treatment processes.

Funder

the Korea Health Technology R&D Project through the Korea Health Industry Development In-stitute (KHIDI).

Publisher

MDPI AG

Subject

Medicine (miscellaneous)

Reference32 articles.

1. Hong, J.S., Wasden, C., and Han, D.H. (2021). Introduction of digital therapeutics. Comput. Methods Programs Biomed., 209.

2. Digital Therapeutics Alliance (DTA) (2020, January 09). Available online: www.dtxalliance.org.

3. Digital Therapeutics Alliance (DTA) (2022, September 10). Combining Technology and Evidence-Based Medicine to Transform Personalized Patient Care. Available online: https://global-3h.com/2020/01/14/digital-healthcare-combining-technology-and-evidence-based-medicine-to-transform-personalized-patient-care/.

4. Long-term outcomes of a web-based diabetes prevention program: 2-year results of a single-arm longitudinal study;Sepah;J. Med. Internet Res.,2015

5. (2022). Markets and Markets. Digital therapeutics (DTx) market—Global forecasts to 2027. ASD Rep.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3